BlackRock’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1K | Sell |
1,690
-58,690
| -97% | -$526K | ﹤0.01% | 5102 |
|
|
2025
Q1 | $381K | Sell |
60,380
-1,816
| -3% | -$11.5K | ﹤0.01% | 4418 |
|
|
2024
Q4 | $642K | Buy |
62,196
+2,323
| +4% | +$24K | ﹤0.01% | 4295 |
|
|
2024
Q3 | $769K | Buy |
59,873
+3,273
| +6% | +$42.1K | ﹤0.01% | 4182 |
|
|
2024
Q2 | $783K | Buy |
56,600
+53,562
| +1,763% | +$741K | ﹤0.01% | 4187 |
|
|
2024
Q1 | $945K | Buy |
3,038
+822
| +37% | +$256K | ﹤0.01% | 4153 |
|
|
2023
Q4 | $581K | Buy |
2,216
+1,266
| +133% | +$332K | ﹤0.01% | 4317 |
|
|
2023
Q3 | $186K | Sell |
950
-22
| -2% | -$4.3K | ﹤0.01% | 4632 |
|
|
2023
Q2 | $200K | Buy |
972
+144
| +17% | +$29.6K | ﹤0.01% | 4648 |
|
|
2023
Q1 | $83.2K | Buy |
828
+26
| +3% | +$2.61K | ﹤0.01% | 4917 |
|
|
2022
Q4 | $126K | Buy |
802
+22
| +3% | +$3.46K | ﹤0.01% | 4888 |
|
|
2022
Q3 | $196K | Sell |
780
-52
| -6% | -$13.1K | ﹤0.01% | 4892 |
|
|
2022
Q2 | $235K | Buy |
832
+452
| +119% | +$128K | ﹤0.01% | 4904 |
|
|
2022
Q1 | $77K | Buy |
380
+15
| +4% | +$3.04K | ﹤0.01% | 5253 |
|
|
2021
Q4 | $80K | Buy |
365
+9
| +3% | +$1.97K | ﹤0.01% | 5251 |
|
|
2021
Q3 | $163K | Sell |
356
-46
| -11% | -$21.1K | ﹤0.01% | 4963 |
|
|
2021
Q2 | $161K | Sell |
402
-6,566
| -94% | -$2.63M | ﹤0.01% | 4873 |
|
|
2021
Q1 | $4.04M | Buy |
6,968
+1,685
| +32% | +$976K | ﹤0.01% | 3973 |
|
|
2020
Q4 | $3.01M | Buy |
5,283
+1,136
| +27% | +$648K | ﹤0.01% | 3824 |
|
|
2020
Q3 | $2.32M | Buy |
4,147
+42
| +1% | +$23.5K | ﹤0.01% | 3767 |
|
|
2020
Q2 | $2.33M | Buy |
+4,105
| New | +$2.33M | ﹤0.01% | 3704 |
|